BIOTA PHARMACEUTICALS Trademark

Trademark Overview

On Tuesday, January 22, 2013, a trademark application was filed for BIOTA PHARMACEUTICALS with the United States Patent and Trademark Office. The USPTO has given the BIOTA PHARMACEUTICALS trademark a serial number of 79128664. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Sunday, January 22, 2023. This trademark is owned by Biota Pharmaceuticals, Inc.. The BIOTA PHARMACEUTICALS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Vaccines; pharmaceutical preparations and drugs, namely, anti-infective agents, anti-inflammatory agents, antiviral agents, antimicrobial agents for medical purposes, antibacterial agents, antifungal agents, agents for respiratory conditions and infections; and diagnostic preparations for medical purposes

Pharmaceutical and chemical research and development
biota pharmaceuticals

General Information

Serial Number79128664
Word MarkBIOTA PHARMACEUTICALS
Filing DateTuesday, January 22, 2013
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateSunday, January 22, 2023
Registration Number4503677
Registration DateTuesday, April 1, 2014
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 14, 2014

Trademark Statements

Goods and ServicesVaccines; pharmaceutical preparations and drugs, namely, anti-infective agents, anti-inflammatory agents, antiviral agents, antimicrobial agents for medical purposes, antibacterial agents, antifungal agents, agents for respiratory conditions and infections; and diagnostic preparations for medical purposes
Disclaimer with Predetermined Text"PHARMACEUTICALS"
Goods and ServicesPharmaceutical and chemical research and development

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, February 26, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, February 26, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAVIRAGEN THERAPEUTICS, INC.
Party Type30 - Original Registrant
Legal Entity Type11 - Company
AddressUS
Party NameBiota Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type11 - Company
AddressUS
Party NameBiota Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type11 - Company
AddressUS

Trademark Events

Event DateEvent Description
Saturday, August 19, 2023NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Saturday, August 19, 2023DEATH OF INTERNATIONAL REGISTRATION
Saturday, March 12, 2022TOTAL INVALIDATION PROCESSED BY THE IB
Monday, February 7, 2022TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Monday, February 7, 2022INVALIDATION PROCESSED
Tuesday, October 26, 2021TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, February 26, 2021CANCELLED SECTION 71
Thursday, April 11, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, April 1, 2019COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, May 18, 2018CHANGE OF NAME/ADDRESS REC'D FROM IB
Thursday, July 31, 2014FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, July 15, 2014FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, July 15, 2014FINAL DISPOSITION PROCESSED
Tuesday, July 1, 2014FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Thursday, June 5, 2014CHANGE OF NAME/ADDRESS REC'D FROM IB
Monday, March 31, 2014ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, March 31, 2014TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, April 1, 2014REGISTERED-PRINCIPAL REGISTER
Tuesday, January 14, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 14, 2014PUBLISHED FOR OPPOSITION
Saturday, January 11, 2014NOTIFICATION PROCESSED BY IB
Wednesday, December 25, 2013NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, December 25, 2013NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, December 25, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 10, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, December 5, 2013ASSIGNED TO LIE
Tuesday, November 12, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, November 12, 2013EXAMINER'S AMENDMENT ENTERED
Tuesday, November 12, 2013NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, November 12, 2013EXAMINERS AMENDMENT E-MAILED
Tuesday, November 12, 2013EXAMINERS AMENDMENT -WRITTEN
Friday, November 8, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, November 7, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, November 7, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, October 9, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, October 9, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sunday, May 26, 2013REFUSAL PROCESSED BY IB
Thursday, May 9, 2013NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, May 9, 2013REFUSAL PROCESSED BY MPU
Thursday, May 9, 2013NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, May 8, 2013NON-FINAL ACTION WRITTEN
Tuesday, May 7, 2013APPLICATION FILING RECEIPT MAILED
Monday, May 6, 2013ASSIGNED TO EXAMINER
Friday, May 3, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, May 2, 2013SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

pharmaceuticals biota agents medical anti purposes pharmaceutical preparations conditions respiratory infections chemical